3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Cardiotoxicity
6
Lymphoma, Non-Hodgkin
4
Lymphoma
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Leukemia
2
Cardiovascular Diseases
2
Small Cell Lung Carcinoma
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Effusion
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lung Neoplasms
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Heart Failure
1
Epstein-Barr Virus Infections
1
Interventions
fludarabine
19
Whole-Body Irradiation
18
Cyclophosphamide
17
fludarabine phosphate
16
ruxolitinib
15
Mycophenolic Acid
14
Specimen Handling
13
Tacrolimus
11
Azacitidine
11
Biopsy
10
Peripheral Blood Stem Cell Transplantation
9
Melphalan
9
Cytarabine
9
venetoclax
8
Sirolimus
8
Busulfan
8
Stem Cell Transplantation
6
Injections
6
Granulocyte Colony-Stimulating Factor
6
Daunorubicin
5
Cyclosporine
5
CPX-351
5
luspatercept
4
ivosidenib
4
itacitinib
4
fedratinib
4
decitabine and cedazuridine drug combination
4
Thiotepa
4
Liposomes
4
Cyclosporins
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Echocardiography
×
1 year
×
Clear all
No trials found.